2016

  1. Allogeneic adipose-derived mesenchymal stem cells (Cx601) in perianal CD

  2. Granulocyte/Monocyte Apheresis in UC

  3. Consistent Prebiotic Effect on Gut Microbiota With Altered FODMAP Intake in Patients with CD

  4. Infliximab vs cyclosporine in ASUC

  5. Adalimumab +/- azathioprine in CD

  6. Eldelumab [Anti-IP-10] Induction Therapy for Ulcerative Colitis: A Randomised, Placebo-Controlled, Phase 2b Study

  7. Ustekinumab in CD safety

  8. Treatment of CD with an IgG4-Guided Exclusion Diet